Found: 293
Select item for more details and to access through your institution.
Stockout of anti-TB drugs: Are we going to lose the gains achieved in year 2022--2023?
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Characteristics and outcomes of patients with relapsed Philadelphia chromosome‐positive acute lymphoblastic leukemia after failure of a frontline ponatinib‐containing therapy.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 7, p. 1423, doi. 10.1002/ajh.27329
- By:
- Publication type:
- Article
Safety and long‐term survival results of the addition of inotuzumab ozogamicin to the conditioning regimen of allogeneic stem cell transplantation: A single‐center phase 1,2 trial.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 5, p. 836, doi. 10.1002/ajh.27254
- By:
- Publication type:
- Article
Phase II study of cladribine, idarubicin, and ara‐C (CLIA) with or without sorafenib as initial therapy for patients with acute myeloid leukemia.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 11, p. 1711, doi. 10.1002/ajh.27054
- By:
- Publication type:
- Article
Characteristics and outcomes of patients with chronic myeloid leukemia and T315I mutation treated in the pre‐ and post‐ponatinib era.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 10, p. 1619, doi. 10.1002/ajh.27037
- By:
- Publication type:
- Article
Ultrasensitive NGS MRD assessment in Ph+ ALL: Prognostic impact and correlation with RT‐PCR for BCR::ABL1.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 8, p. 1196, doi. 10.1002/ajh.26949
- By:
- Publication type:
- Article
Outcomes of adult patients with relapsed/refractory CRLF2 rearranged B‐cell acute lymphoblastic leukemia.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 6, p. E142, doi. 10.1002/ajh.26907
- By:
- Publication type:
- Article
The outcomes of patients with chronic myeloid leukemia treated with third‐line BCR::ABL1 tyrosine kinase inhibitors.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 4, p. 658, doi. 10.1002/ajh.26852
- By:
- Publication type:
- Article
Frontline combination of ponatinib and hyper‐CVAD in Philadelphia chromosome‐positive acute lymphoblastic leukemia: 80‐months follow‐up results.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 3, p. 493, doi. 10.1002/ajh.26816
- By:
- Publication type:
- Article
Intrathecal prophylaxis with 12 versus 8 administrations reduces the incidence of central nervous system relapse in patients with newly diagnosed Philadelphia chromosome positive acute lymphoblastic leukemia.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 1, p. E11, doi. 10.1002/ajh.26622
- By:
- Publication type:
- Article
Low‐dose dasatinib 50 mg/day versus standard‐dose dasatinib 100 mg/day as frontline therapy in chronic myeloid leukemia in chronic phase: A propensity score analysis.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 11, p. 1413, doi. 10.1002/ajh.26689
- By:
- Publication type:
- Article
Blinatumomab is associated with favorable outcomes in patients with B‐cell lineage acute lymphoblastic leukemia and positive measurable residual disease at a threshold of 10<sup>−4</sup> and higher.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 9, p. 1135, doi. 10.1002/ajh.26634
- By:
- Publication type:
- Article
TP53‐altered chronic lymphocytic leukemia treated with firstline Bruton's tyrosine kinase inhibitor‐based therapy: A retrospective analysis.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 8, p. 1005, doi. 10.1002/ajh.26595
- By:
- Publication type:
- Article
Venetoclax combined with FLAG‐IDA induction and consolidation in newly diagnosed acute myeloid leukemia.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 8, p. 1035, doi. 10.1002/ajh.26601
- By:
- Publication type:
- Article
Urgent cytoreduction for newly diagnosed acute myeloid leukemia patients allows acquisition of pretreatment genomic data and enrollment on investigational clinical trials.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 7, p. 885, doi. 10.1002/ajh.26572
- By:
- Publication type:
- Article
Treatment‐free remission in patients with chronic myeloid leukemia following the discontinuation of tyrosine kinase inhibitors.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 7, p. 856, doi. 10.1002/ajh.26550
- By:
- Publication type:
- Article
Prediction of survival with intensive chemotherapy in acute myeloid leukemia.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 7, p. 865, doi. 10.1002/ajh.26557
- By:
- Publication type:
- Article
Dismal outcomes of patients with relapsed/refractory Philadelphia chromosome‐negative B‐cell acute lymphoblastic leukemia after failure of both inotuzumab ozogamicin and blinatumomab.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 6, p. E201, doi. 10.1002/ajh.26526
- By:
- Publication type:
- Article
Non‐coding NOTCH1 mutations in chronic lymphocytic leukemia negatively impact prognosis.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 3, p. E100, doi. 10.1002/ajh.26457
- By:
- Publication type:
- Article
Prediction of early (4‐week) mortality in acute myeloid leukemia with intensive chemotherapy.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 1, p. 68, doi. 10.1002/ajh.26395
- By:
- Publication type:
- Article
Impact of Philadelphia chromosome‐like alterations on efficacy and safety of blinatumomab in adults with relapsed/refractory acute lymphoblastic leukemia: A post hoc analysis from the phase 3 TOWER study.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 10, p. E379, doi. 10.1002/ajh.26281
- By:
- Publication type:
- Article
Inotuzumab ozogamicin with bosutinib for relapsed or refractory Philadelphia chromosome positive acute lymphoblastic leukemia or lymphoid blast phase of chronic myeloid leukemia.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 8, p. 1000, doi. 10.1002/ajh.26238
- By:
- Publication type:
- Article
Long‐term results of low‐intensity chemotherapy with clofarabine or cladribine combined with low‐dose cytarabine alternating with decitabine in older patients with newly diagnosed acute myeloid leukemia.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 8, p. 914, doi. 10.1002/ajh.26206
- By:
- Publication type:
- Article
An effective chemotherapy‐free regimen of ponatinib plus venetoclax for relapsed/refractory Philadelphia chromosome‐positive acute lymphoblastic leukemia.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 7, p. E229, doi. 10.1002/ajh.26175
- By:
- Publication type:
- Article
Acute lymphoblastic leukemia: A population‐based study of outcome in the United States based on the surveillance, epidemiology, and end results (SEER) database, 1980–2017.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 6, p. 650, doi. 10.1002/ajh.26156
- By:
- Publication type:
- Article
Outcome of T‐cell acute lymphoblastic leukemia/lymphoma: Focus on near‐ETP phenotype and differential impact of nelarabine.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 5, p. 589, doi. 10.1002/ajh.26144
- By:
- Publication type:
- Article
Venetoclax with decitabine vs intensive chemotherapy in acute myeloid leukemia: A propensity score matched analysis stratified by risk of treatment‐related mortality.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 3, p. 282, doi. 10.1002/ajh.26061
- By:
- Publication type:
- Article
GATA3 rs3824662A allele in B‐cell acute lymphoblastic leukemia in adults, adolescents and young adults: association with CRLF2 rearrangement and poor prognosis.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 3, p. E71, doi. 10.1002/ajh.26065
- By:
- Publication type:
- Article
Outcome of adults with relapsed/refractory T‐cell acute lymphoblastic leukemia or lymphoblastic lymphoma.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 9, p. E245, doi. 10.1002/ajh.25896
- By:
- Publication type:
- Article
Phase 2 study of hyper‐CMAD with liposomal vincristine for patients with newly diagnosed acute lymphoblastic leukemia.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 7, p. 734, doi. 10.1002/ajh.25784
- By:
- Publication type:
- Article
The early achievement of measurable residual disease negativity in the treatment of adults with Philadelphia‐negative B‐cell acute lymphoblastic leukemia is a strong predictor for survival.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 2, p. 144, doi. 10.1002/ajh.25671
- By:
- Publication type:
- Article
Philadelphia chromosome‐positive acute lymphoblastic leukemia at first relapse in the era of tyrosine kinase inhibitors.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 12, p. 1388, doi. 10.1002/ajh.25648
- By:
- Publication type:
- Article
Duvelisib, an oral dual PI3K‐δ,γ inhibitor, shows clinical and pharmacodynamic activity in chronic lymphocytic leukemia and small lymphocytic lymphoma in a phase 1 study.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 11, p. 1318, doi. 10.1002/ajh.25243
- By:
- Publication type:
- Article
Clinical experience with the BCL2‐inhibitor venetoclax in combination therapy for relapsed and refractory acute myeloid leukemia and related myeloid malignancies.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 3, p. 401, doi. 10.1002/ajh.25000
- By:
- Publication type:
- Article
Outcome of patients with relapsed/refractory acute lymphoblastic leukemia after blinatumomab failure: No change in the level of CD19 expression.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 3, p. 371, doi. 10.1002/ajh.24987
- By:
- Publication type:
- Article
Hyper-CVAD plus nelarabine in newly diagnosed adult T-cell acute lymphoblastic leukemia and T-lymphoblastic lymphoma.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 1, p. 91, doi. 10.1002/ajh.24947
- By:
- Publication type:
- Article
Clinical outcomes in adult patients with aplastic anemia: A single institution experience.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 12, p. 1295, doi. 10.1002/ajh.24897
- By:
- Publication type:
- Article
Clinical characteristics and outcomes of previously untreated patients with adult onset T-acute lymphoblastic leukemia and T-lymphoblastic lymphoma with hyper-CVAD based regimens.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 10, p. E595, doi. 10.1002/ajh.24833
- By:
- Publication type:
- Article
A phase 1 study of AMG 900, an orally administered pan-aurora kinase inhibitor, in adult patients with acute myeloid leukemia.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 7, p. 660, doi. 10.1002/ajh.24736
- By:
- Publication type:
- Article
PET-positive lymphadenopathy in CLL-Not always Richter transformation.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 4, p. 405, doi. 10.1002/ajh.24566
- By:
- Publication type:
- Article
Poor outcomes associated with +der(22)t(9;22) and −9/9p in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia receiving chemotherapy plus a tyrosine kinase inhibitor.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 3, p. 238, doi. 10.1002/ajh.24625
- By:
- Publication type:
- Article
Significance of recurrence of minimal residual disease detected by multi-parameter flow cytometry in patients with acute lymphoblastic leukemia in morphological remission.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 3, p. 279, doi. 10.1002/ajh.24629
- By:
- Publication type:
- Article
Dorsal column myelopathy after intrathecal chemotherapy for leukemia.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 2, p. 155, doi. 10.1002/ajh.24611
- By:
- Publication type:
- Article
Histologic transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 10, p. 1036, doi. 10.1002/ajh.24473
- By:
- Publication type:
- Article
Prognostic impact of persistent cytogenetic abnormalities at complete remission in adult patients with acute lymphoblastic leukemia.
- Published in:
- American Journal of Hematology, 2016, v. 91, p. 385, doi. 10.1002/ajh.24296
- By:
- Publication type:
- Article
Prognostic impact of persistent cytogenetic abnormalities at complete remission in adult patients with acute lymphoblastic leukemia.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 4, p. 385, doi. 10.1002/ajh.24296
- By:
- Publication type:
- Article
TET2 mutations, myelodysplastic features, and a distinct immunoprofile characterize blastic plasmacytoid dendritic cell neoplasm in the bone marrow.
- Published in:
- American Journal of Hematology, 2013, v. 88, n. 12, p. 1055, doi. 10.1002/ajh.23567
- By:
- Publication type:
- Article
The Use of Dixon Magnetic Resonance Imaging Methods for the Quantification of Rotator Cuff Fatty Infiltration: A Systematic Review.
- Published in:
- Muscles (2813-0413), 2024, v. 3, n. 2, p. 133, doi. 10.3390/muscles3020013
- By:
- Publication type:
- Article
A COMPREHENSIVE SURVEY ON LOAD BALANCING TECHNIQUES FOR VIRTUAL MACHINES.
- Published in:
- System Research & Information Technologies / Sistemnì Doslìdžennâ ta Ìnformacìjnì Tehnologìï, 2023, n. 4, p. 135, doi. 10.20535/SRIT.2308-8893.2023.4.10
- By:
- Publication type:
- Article
The Prolapsed Intussusceptum in a 4-month-old Male: A Case Report.
- Published in:
- Journal of Pediatrics Review, 2021, v. 9, n. 2, p. 163, doi. 10.32598/jpr.9.2.892.1
- By:
- Publication type:
- Article